RVXCF Message Board Post 9191560 | Resverlogix Corp
home / stock / rvxcf / rvxcf message board
dangeline9
(investorshub)
Posted on: Apr/21/2020 15:01:14
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155156064
With all that has been shown in the
News, Short Squeeze, Breakout and More Instantly...
-
2024-03-27 17:08:02 ET Developing safe, epigenetic therapeutics for people suffering from chronic illnesses Resverlogix is a late-stage clinical biotechnology company dedicated to improving the lives of patients with chronic illnesses and providing value-based health solutions...
-
2024-03-27 17:08:02 ET The future of drug development Resverlogix is committed to developing epigenetic therapies for the benefit of patients with chronic disease. Their current clinical program focuses on advancing their lead compound ( apabetalone) and evaluating its th...
-
Calgary, Alberta--(Newsfile Corp. - February 21, 2024) - Resverlogix Corp. (TSX: RVX) ("Resverlogix" or the "Company") today announced that Shawn Lu has stepped down from the Board of Directors, effective today. "We would like to thank Shawn for his contributions and wish him all the best," said ...